Four Penn Dental Medicine Faculty Issued Patents in FY22

Philadelphia – Penn Dental Medicine faculty members were recognized for their research and innovation as part of the Penn Center for Innovation’s (PCI) 7th annual Celebration of Innovation. This annual event celebrates Penn researchers and innovators who were named as inventors on patents issued to Penn this past fiscal year and highlights significant commercialization achievements. The celebration was held December 6 at the Singh Center for Nanotechnology.

Craig Carnaroli, Senior Executive Vice President, University of Pennsylvania, provided a keynote address highlighting the origins of PCI, the progression of technology innovation at Penn and its importance in driving Philadelphia’s innovation ecosystem.

Those Penn Dental Medicine faculty issued patents in FY22 included:

• Dr. Henry Daniell, Vice Chair and W.D. Miller Professor, Dept. of Basic & Translational Sciences, for Oral Delivery of Angiotensin Converting Enzyme 2 (Ace2) Or Angiotensin-(1-7)-Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension, Cardiac Dysfunction and Development of Autoimmune and Experimentally Induced Ocular Disorders; Codon Optimization and Ribosome Profiling for Increasing Transgene Expression in Chloroplasts of Higher Plants; and a third patent for Compositions and Methods for Inhibiting Biofilm Deposition and Production.
• Dr. Kathleen Boesze-Battaglia, Professor, Dept. of Basic & Translational Sciences, for Compositions and Methods Useful in Treating Stargardt’S Disease and Other Ocular Disorders.
• Dr. Gary Cohen, Professor, Dept. of Basic & Translational Sciences, for Modified mRNA Vaccines Encoding Herpes Simplex Virus Glycoproteins and Uses Thereof.
• Dr. Michel Koo, Professor, Dept. of Orthodontics and Divs. of Pediatrics and Community Oral Health, along with Dr. Daniell for Compositions and Methods for Inhibiting Biofilm Deposition and Production.

Penn had a record 929 patents filed in FY22. Read about PCI’s FY22 in Review >>